Mystic Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.88M | Buy |
20,879
+26
| +0.1% | +$4.83K | 0.94% | 26 |
|
2025
Q1 | $4.37M | Sell |
20,853
-470
| -2% | -$98.5K | 1.15% | 22 |
|
2024
Q4 | $3.79M | Buy |
21,323
+5,770
| +37% | +$1.03M | 1.02% | 26 |
|
2024
Q3 | $3.07M | Sell |
15,553
-204
| -1% | -$40.3K | 1.16% | 20 |
|
2024
Q2 | $2.7M | Buy |
15,757
+109
| +0.7% | +$18.7K | 1.09% | 24 |
|
2024
Q1 | $2.85M | Buy |
15,648
+551
| +4% | +$100K | 1.18% | 24 |
|
2023
Q4 | $2.34M | Sell |
15,097
-719
| -5% | -$111K | 1.12% | 24 |
|
2023
Q3 | $2.36M | Buy |
15,816
+75
| +0.5% | +$11.2K | 1.32% | 23 |
|
2023
Q2 | $2.12M | Sell |
15,741
-399
| -2% | -$53.8K | 1.14% | 26 |
|
2023
Q1 | $2.57M | Sell |
16,140
-20
| -0.1% | -$3.19K | 1.42% | 17 |
|
2022
Q4 | $2.61M | Buy |
16,160
+25
| +0.2% | +$4.04K | 1.48% | 16 |
|
2022
Q3 | $2.17M | Buy |
16,135
+100
| +0.6% | +$13.4K | 1.39% | 17 |
|
2022
Q2 | $2.46M | Buy |
16,035
+715
| +5% | +$109K | 1.5% | 14 |
|
2022
Q1 | $2.48M | Sell |
15,320
-500
| -3% | -$81K | 1.34% | 18 |
|
2021
Q4 | $2.14M | Buy |
+15,820
| New | +$2.14M | 1.01% | 24 |
|